Immutep reports strong response rate from immunotherapies treating carcinomas
Immutep Ltd has reported a slew of positive results from a trial to assess a combination of immunotherapy cancer drugs.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GOV | Ann: Month end units on issue | 04/07/24 | 0 | 53 | |||
|
|||||||
GOV | Ann: DRP Distribution Announcement June 2024 | 03/07/24 | 0 | 53 | |||
|
|||||||
GOV | Ann: Distribution Announcement June 2024 | 27/06/24 | 0 | 56 | |||
|
|||||||
GOV | Ann: Distribution Estimate | 18/06/24 | 0 | 80 | |||
|
|||||||
GOV | Ann: Month end units on issue | 06/06/24 | 0 | 64 | |||
|
|||||||
GOV | Ann: Month end units on issue | 06/05/24 | 0 | 83 | |||
|
|||||||
GOV | Ann: DRP Distribution Announcement March 2024 | 04/04/24 | 0 | 101 | |||
|
|||||||
GOV | Ann: Month end units on issue | 03/04/24 | 0 | 95 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |